![Cancers | Free Full-Text | Epstein–Barr Virus Promotes B Cell Lymphomas by Manipulating the Host Epigenetic Machinery | HTML Cancers | Free Full-Text | Epstein–Barr Virus Promotes B Cell Lymphomas by Manipulating the Host Epigenetic Machinery | HTML](https://www.mdpi.com/cancers/cancers-12-03037/article_deploy/html/images/cancers-12-03037-g001.png)
Cancers | Free Full-Text | Epstein–Barr Virus Promotes B Cell Lymphomas by Manipulating the Host Epigenetic Machinery | HTML
![Progress and Problems in Understanding and Managing Primary Epstein-Barr Virus Infections | Clinical Microbiology Reviews Progress and Problems in Understanding and Managing Primary Epstein-Barr Virus Infections | Clinical Microbiology Reviews](https://journals.asm.org/cms/10.1128/CMR.00044-10/asset/cc13d41f-0a67-42c6-b353-bcc2d249468e/assets/graphic/zcm9990923420002.jpeg)
Progress and Problems in Understanding and Managing Primary Epstein-Barr Virus Infections | Clinical Microbiology Reviews
![Epstein–Barr virus tegument protein BGLF2 in exosomes released from virus-producing cells facilitates de novo infection | Cell Communication and Signaling | Full Text Epstein–Barr virus tegument protein BGLF2 in exosomes released from virus-producing cells facilitates de novo infection | Cell Communication and Signaling | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12964-022-00902-7/MediaObjects/12964_2022_902_Figa_HTML.png)
Epstein–Barr virus tegument protein BGLF2 in exosomes released from virus-producing cells facilitates de novo infection | Cell Communication and Signaling | Full Text
![Epstein–Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies: Trends in Molecular Medicine Epstein–Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies: Trends in Molecular Medicine](https://www.cell.com/cms/attachment/3d5690df-0de6-493c-8788-cf4d81073686/gr1_lrg.jpg)
Epstein–Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies: Trends in Molecular Medicine
![EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count - International Journal of Infectious Diseases EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count - International Journal of Infectious Diseases](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/7c02685e-e8f4-4d61-bd86-452f6cb68de8/gr1_lrg.jpg)
EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count - International Journal of Infectious Diseases
![Epidemiological risk factors associated with primary infection by Epstein–Barr virus in HIV-1-positive subjects in the Brazilian Amazon region | Scientific Reports Epidemiological risk factors associated with primary infection by Epstein–Barr virus in HIV-1-positive subjects in the Brazilian Amazon region | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-97707-4/MediaObjects/41598_2021_97707_Fig1_HTML.png)
Epidemiological risk factors associated with primary infection by Epstein–Barr virus in HIV-1-positive subjects in the Brazilian Amazon region | Scientific Reports
![Frontiers | The CD8 T Cell-Epstein-Barr Virus-B Cell Trialogue: A Central Issue in Multiple Sclerosis Pathogenesis Frontiers | The CD8 T Cell-Epstein-Barr Virus-B Cell Trialogue: A Central Issue in Multiple Sclerosis Pathogenesis](https://www.frontiersin.org/files/MyHome%20Article%20Library/665718/665718_Thumb_400.jpg)
Frontiers | The CD8 T Cell-Epstein-Barr Virus-B Cell Trialogue: A Central Issue in Multiple Sclerosis Pathogenesis
![Cancers | Free Full-Text | Epstein–Barr Virus—Associated Malignancies and Immune Escape: The Role of the Tumor Microenvironment and Tumor Cell Evasion Strategies | HTML Cancers | Free Full-Text | Epstein–Barr Virus—Associated Malignancies and Immune Escape: The Role of the Tumor Microenvironment and Tumor Cell Evasion Strategies | HTML](https://www.mdpi.com/cancers/cancers-13-05189/article_deploy/html/images/cancers-13-05189-g001.png)
Cancers | Free Full-Text | Epstein–Barr Virus—Associated Malignancies and Immune Escape: The Role of the Tumor Microenvironment and Tumor Cell Evasion Strategies | HTML
![DNA immunotherapy targeting BARF1 induces potent anti-tumor responses against Epstein-Barr-virus-associated carcinomas: Molecular Therapy - Oncolytics DNA immunotherapy targeting BARF1 induces potent anti-tumor responses against Epstein-Barr-virus-associated carcinomas: Molecular Therapy - Oncolytics](https://www.cell.com/cms/asset/41afef97-6285-4e18-8e94-61501be728ba/fx1.jpg)
DNA immunotherapy targeting BARF1 induces potent anti-tumor responses against Epstein-Barr-virus-associated carcinomas: Molecular Therapy - Oncolytics
Gruppo San Donato - ANTICORPI ANTI VIRUS EPSTEIN-BARR (EBV): QUALI TEST? Sono disponibili molti test in grado di rilevare i differenti tipi e classi di anticorpi diretti contro EBV. “Gli anticorpi, ci
![An Antibody Targeting the Fusion Machinery Neutralizes Dual-Tropic Infection and Defines a Site of Vulnerability on Epstein-Barr Virus - ScienceDirect An Antibody Targeting the Fusion Machinery Neutralizes Dual-Tropic Infection and Defines a Site of Vulnerability on Epstein-Barr Virus - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1074761318301249-fx1.jpg)